Millennial Scientific End Of Year Review 2025

In 2025, Millennial Scientific made substantial progress. We introduced new products, advanced our sustainability efforts, and expanded our technical capabilities. Below is our End-of-Year Review.

New product innovations: We launched two major product lines for biologic purification: NanoPak-C All Carbon Perfusion Microbeads and scalable, custom NanoPak-C Monolith Media. These products improve purification efficiency for large biologics, including protein complexes, exosomes, virus particles, and other advanced modalities.

Commitment to sustainability: To reinforce our circular economy goals, we partnered with Leach Particle Technologies to launch a recycling program for our NanoPak-C All Carbon chromatography media. This collaboration extends an established column-recycling program in the UK and Europe to include our media. It supports end-of-life strategies that minimize, reuse, and recycle high-value carbon materials, reducing waste and the environmental burden.

Advancing peptide purification: We shared new data on the purification of GLP-1 and Sovateltide peptides using NanoPak C All Carbon microbeads. Our blogs on managing impurities in GLP-1 peptides and benchmarking all-carbon microbeads demonstrated how NanoPak C carbon media addresses demanding selectivity and impurity challenges in the rapidly growing diabetes and weight-loss peptide markets.

Tackling environmental challenges: We highlighted how NanoPak C media can support solutions to global environmental issues by discussing new approaches to PFAS challenges and by sharing educational content on organochlorine pesticide analysis. These efforts demonstrate how advanced carbon architectures can be applied beyond biopharma, into environmental and food safety testing.

Customer support initiatives: We continued to support the scientific community by publishing practical technical resources, including guidance on extending HPLC column lifetimes, managing column contamination, and understanding pharmaceutical purity, assay, and potency assessment by liquid chromatography.

Looking ahead to 2026, we plan to:

• Grow our range of sustainable chromatography solutions.

• Share more technical resources focused on complex and emerging biologics.

• Continue scaling and improving our manufacturing capabilities.

• Keep focusing on customer-centered research, development, and technical support.